Literature DB >> 16239533

Characterization of two novel cryptococcal mannoproteins recognized by immune sera.

Carmelo Biondo1, Luciano Messina, Mauro Bombaci, Giuseppe Mancuso, Angelina Midiri, Concetta Beninati, Valentina Cusumano, Elisabetta Gerace, Salvatore Papasergi, Giuseppe Teti.   

Abstract

Host defenses against the encapsulated yeast Cryptococcus neoformans involve both humoral and cell-mediated immunity. Mannoproteins (MPs) are a heterogeneous class of immunodominant glycoproteins which have been only incompletely characterized. In this study, we report on the molecular features of two novel MPs that are recognized by serum antibodies during cryptococcosis. After fractionation of extracellular cryptococcal products, MPs reacted more strongly than other components with sera from C. neoformans-infected AIDS patients. Further fractionation and Western blot analysis of MPs evidenced the presence of highly reactive bands with molecular masses of 250, 125, 115, and 84 kDa. The 115- and 84-kDa bands contained significant amounts of N-linked oligosaccharides, as shown by decreased molecular mass after peptide-N-glycosidase F treatment. N-terminal amino acid sequences of the two bands were used to search C. neoformans nucleotide databases. Homologous genomic sequences were used to synthesize DNA probes and isolate cDNA clones containing the full-length genes, which were designated MP84 and MP115. Both genes showed the presence of a serine/threonine-rich region, a potential site for heavy glycosylation. MP84 and MP115 showed homology with, respectively, polysaccharide deacetylases and carboxylesterases from other organisms. Recombinant, deglycosylated proteins expressed in Escherichia coli still reacted with sera from patients, albeit more weakly than natural MPs, indicating that at least some of the reactive epitopes were retained in the recombinant forms. In conclusion, we identified two novel MPs that are important targets of antibody responses during cryptococcosis. These data may be useful to devise alternative immunity-based strategies to control the disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16239533      PMCID: PMC1273869          DOI: 10.1128/IAI.73.11.7348-7355.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

Review 1.  New concepts in antibody-mediated immunity.

Authors:  Arturo Casadevall; Liise-anne Pirofski
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

2.  MyD88 and TLR2, but not TLR4, are required for host defense against Cryptococcus neoformans.

Authors:  Carmelo Biondo; Angelina Midiri; Luciano Messina; Francesco Tomasello; Gabriella Garufi; Maria Rosaria Catania; Mauro Bombaci; Concetta Beninati; Giuseppe Teti; Giuseppe Mancuso
Journal:  Eur J Immunol       Date:  2005-03       Impact factor: 5.532

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Molecular characterization of a mannoprotein with homology to chitin deacetylases that stimulates T cell responses to Cryptococcus neoformans.

Authors:  S M Levitz; S Nong ; M K Mansour; C Huang; C A Specht
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

5.  Identification and cloning of a cryptococcal deacetylase that produces protective immune responses.

Authors:  Carmelo Biondo; Concetta Beninati; Demetrio Delfino; Marco Oggioni; Giuseppe Mancuso; Angelina Midiri; Mauro Bombaci; Giuseppe Tomaselli; Giuseppe Teti
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

6.  Purification and characterization of a second immunoreactive mannoprotein from Cryptococcus neoformans that stimulates T-Cell responses.

Authors:  Chao Huang; Shu-Hua Nong; Michael K Mansour; Charles A Specht; Stuart M Levitz
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

7.  Induction of T helper type 1 responses by a polysaccharide deacetylase from Cryptococcus neoformans.

Authors:  Carmelo Biondo; Concetta Beninati; Mauro Bombaci; Luciano Messina; Giuseppe Mancuso; Angelina Midiri; Roberta Galbo; Giuseppe Teti
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

8.  Protective efficacy of antigenic fractions in mouse models of cryptococcosis.

Authors:  Michael K Mansour; Lauren E Yauch; James B Rottman; Stuart M Levitz
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

9.  Superoxide dismutase influences the virulence of Cryptococcus neoformans by affecting growth within macrophages.

Authors:  Gary M Cox; Thomas S Harrison; Henry C McDade; Carlos P Taborda; Garrett Heinrich; Arturo Casadevall; John R Perfect
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

10.  Humoral response against Cryptococcus neoformans mannoprotein antigens in HIV-infected patients.

Authors:  L Pitzurra; S Perito; F Baldelli; F Bistoni; A Vecchiarelli
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

View more
  20 in total

1.  Heterogeneous expression of the virulence-related adhesin Epa1 between individual cells and strains of the pathogen Candida glabrata.

Authors:  Samantha C Halliwell; Matthew C A Smith; Philippa Muston; Sara L Holland; Simon V Avery
Journal:  Eukaryot Cell       Date:  2011-12-02

2.  Antibody responses to Cryptococcus neoformans in Indian patients with cryptococcosis.

Authors:  Dolan Champa Saha; Immaculata Xess; Wang Yong Zeng; David L Goldman
Journal:  Med Mycol       Date:  2008-03-10       Impact factor: 4.076

3.  Identification and characterization of Cryptococcus neoformans protein fractions that induce protective immune responses.

Authors:  Ashok K Chaturvedi; Susan T Weintraub; Jose L Lopez-Ribot; Floyd L Wormley
Journal:  Proteomics       Date:  2013-12       Impact factor: 3.984

4.  Unraveling unique structure and biosynthesis pathway of N-linked glycans in human fungal pathogen Cryptococcus neoformans by glycomics analysis.

Authors:  Jeong-Nam Park; Dong-Jik Lee; Ohsuk Kwon; Doo-Byoung Oh; Yong-Sun Bahn; Hyun Ah Kang
Journal:  J Biol Chem       Date:  2012-04-12       Impact factor: 5.157

Review 5.  How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans.

Authors:  Tamara Lea Doering
Journal:  Annu Rev Microbiol       Date:  2009       Impact factor: 15.500

Review 6.  The capsule of the fungal pathogen Cryptococcus neoformans.

Authors:  Oscar Zaragoza; Marcio L Rodrigues; Magdia De Jesus; Susana Frases; Ekaterina Dadachova; Arturo Casadevall
Journal:  Adv Appl Microbiol       Date:  2009       Impact factor: 5.086

7.  A proteomic-based approach for the identification of immunodominant Cryptococcus neoformans proteins.

Authors:  Mattie Young; Sandra Macias; Derek Thomas; Floyd L Wormley
Journal:  Proteomics       Date:  2009-05       Impact factor: 3.984

Review 8.  A Call to Arms: Quest for a Cryptococcal Vaccine.

Authors:  Marley C Caballero Van Dyke; Floyd L Wormley
Journal:  Trends Microbiol       Date:  2017-11-02       Impact factor: 17.079

9.  Vaccine and immunotherapeutic approaches for the prevention of cryptococcosis: lessons learned from animal models.

Authors:  Camaron R Hole; Floyd L Wormley
Journal:  Front Microbiol       Date:  2012-08-28       Impact factor: 5.640

10.  Protective immunity against cryptococcus neoformans infection.

Authors:  Joel Schop
Journal:  Mcgill J Med       Date:  2007-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.